期刊
INTERNATIONAL JOURNAL OF CANCER
卷 124, 期 10, 页码 2375-2383出版社
WILEY
DOI: 10.1002/ijc.24215
关键词
human papillomavirus; anal cancer; anal neoplasia; review; epidemiology
类别
资金
- GlaxoSmitliKline
- University of North Carolina Center of Excellence in Pharmacoepidemiology
A systematic review was conducted of HPV type distribution in anal cancer and anal high-grade and low-grade squalmous intraepithelial lesions (HSIL and LSIL). A Medline search of studies using PCR or hybrid capture for HPV DNA detection was completed. A total of 1,824 cases were included: 992 invasive anal cancers, 472 HSIL cases and 360 LSIL cases. Crude HPV prevalence in anal cancer, HSIL, and LSIL was 71, 91 and 88%, respectively. HPV16/18 prevalence was 72% in invasive anal cancer, 69% in HSIL and 27% in LSIL. The HPV 16 and/or 18 prevalence in invasive anal cancer cases was similar to that reported in invasive cervical cancer. If ongoing clinical trials show efficacy in preventing anal HPV infection and associated anal lesions, prophylactic HPV vaccines may play an important role for the primary prevention of these cancers in both genders. (C) 2008 Wiley-Liss, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据